Your browser doesn't support javascript.
loading
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
Del Campo, Marta; Vermunt, Lisa; Peeters, Carel F W; Sieben, Anne; Hok-A-Hin, Yanaika S; Lleó, Alberto; Alcolea, Daniel; van Nee, Mirrelijn; Engelborghs, Sebastiaan; van Alphen, Juliette L; Arezoumandan, Sanaz; Chen-Plotkin, Alice; Irwin, David J; van der Flier, Wiesje M; Lemstra, Afina W; Teunissen, Charlotte E.
Afiliação
  • Del Campo M; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands. mcampo@barcelonabeta.org.
  • Vermunt L; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. mcampo@barcelonabeta.org.
  • Peeters CFW; Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain. mcampo@barcelonabeta.org.
  • Sieben A; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
  • Hok-A-Hin YS; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
  • Lleó A; Mathematical & Statistical Methods group (Biometris), Wageningen University & Research, Wageningen, The Netherlands.
  • Alcolea D; Lab of neuropathology, Neurobiobank, Institute Born-Bunge, Antwerp University, Edegem, Belgium.
  • van Nee M; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
  • Engelborghs S; Department of Neurology, Institut d'Investigacions Biomèdiques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.
  • van Alphen JL; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Arezoumandan S; Department of Neurology, Institut d'Investigacions Biomèdiques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.
  • Chen-Plotkin A; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Irwin DJ; Department of Epidemiology & Data Science, Amsterdam Public Health research institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
  • van der Flier WM; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Lemstra AW; Vrije Universiteit Brussel, Center for Neurosciences (C4N), Neuroprotection and Neuromodulation Research Group (NEUR), Brussels, Belgium.
  • Teunissen CE; Universitair Ziekenhuis Brussel, Department of Neurology, Brussels, Belgium.
Nat Commun ; 14(1): 5635, 2023 09 13.
Article em En | MEDLINE | ID: mdl-37704597

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença por Corpos de Lewy / Doença de Alzheimer Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença por Corpos de Lewy / Doença de Alzheimer Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda